| Name | chembl2010872 |
|---|---|
| Synonyms | unii-j8ay0z4cbp |
| Description | CEP-11981(ESK981; BOL 303213X) is an orally active tyrosine kinase inhibitor (TKI), which can target TIE2, VEGFR1-3 and FGFR1, and has potential anti-tumor and anti-angiogenic effects[1]. |
|---|---|
| Related Catalog | |
| In Vitro | CEP-11981(1μM, 72 h) 可以显著抑制 RT4 细胞生长[1]。 |
| In Vivo | CEP-11981(2.5 mg/kg、5 mg/kg 或 10 mg/kg,口服强饲法,每天,每周 5 天,持续两周)在 RT4 人 UC 肿瘤小鼠模型中,与对照相比显着抑制了 UC 异种移植物的生长,而小鼠本身重量没有变化[1]。 |
| References |
| Molecular Formula | C28H27N7O |
|---|---|
| Molecular Weight | 477.56000 |
| Exact Mass | 477.22800 |
| PSA | 104.01000 |
| LogP | 4.07950 |